Veradigm and american college of cardiology launch influenza vaccination education initiative to improve cardiovascular health

Chicago--(business wire)-- #healthit--veradigm inc. (nasdaq: mdrx), a leading provider of healthcare data and technology solutions announced today the launch of transform vax, an american college of cardiology (acc)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education. influenza vaccination is associated with a lower risk for adverse cardiovascular events, with an overall 34% lower risk of major adverse cardiovascular events and a 45% lower risk am.
MDRX Ratings Summary
MDRX Quant Ranking